University of Rochester
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Rochester sits in the top decile of US sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count).
University of Rochester: 636 sponsored US clinical trials, 94 recruiting.
University of Rochester sponsors 636 registered US clinical trials on ClinicalTrials.gov, 94 of them currently recruiting, and 448 completed. 54 of these trials are in Phase 3-4 (later-stage) and 147 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 7 trials.
Top-decile sponsor footprint
University of Rochester ranks in the top decile of sponsors by registered trial count (#53 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
448 of 506 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
636 total, page 2 of 13
Study About Group and Phone Follow-Up After a Crisis
NCT05637203
Telehealth-Enhanced Asthma Care for Home After the Emergency Room
NCT05844891
Families Moving Forward (FMF) Connect Pro for Mental Health Providers
NCT05960461
Adapting CBT-I for Hazardous Alcohol Users
NCT05973955
A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer
NCT05530655
The Role of Brain Dopamine in Chronic Pain
NCT05285683
This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.
NCT05946824
Vitamin D for Prostate Endocrine Therapy
NCT05838716
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
NCT06073431
A Single Arm Pilot Trial of a Social Network Intervention
NCT05745038
Vision Loss Impact on Navigation in Virtual Reality
NCT06047717
Comparison of Two Types of Bone Grafts in Patients Who Need One of Their Front Teeth Removed and Replaced With an Implant
NCT06722482
Remote Assessments and Genetic Determinants of Congenital and Childhood Myotonic Dystrophy
NCT07630389
Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma
NCT05597345
Renal Denervation + PVI vs PVI Alone for Persistent AF
NCT05116384
Exercise and Cognitive Rehab in Older Cancer Survivors
NCT05388214
Digital CBT for Insomnia and Depression
NCT05456607
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
NCT05006482
His-Bundle Corrective Pacing in Heart Failure
NCT05265520
Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling
NCT04965064
Povidone Iodine Efficacy Study
NCT05272254
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
NCT05034432
Remote Assessments and Genetic Determinants of Myotonic Dystrophy
NCT07505342
Impact of Increased Body Mass Index on Adolescent Fixed Orthodontic Treatment. A Prospective Longitudinal Study
NCT07217756
Study of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
NCT04805528
A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms
NCT04981821
Imaging of Lymphatic Vessels in People with Rheumatoid Arthritis (RA)
NCT05197530
Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer
NCT04731844
Telehealth Visits to Discuss Advanced Directives for Patients Newly Diagnosed With High Grade Glioma
NCT04543201
Telemedicine Enhanced Asthma Management - Uniting Providers for Teens (TEAM-UP for Teens)
NCT04089046
A Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
NCT04477343
Human Visual and Vestibular Motion Perception Study
NCT04142697
Breathing, Relaxation, Attention Training, & Health in Older Adults (BREATHE)
NCT04522791
Study of Pembrolizumab and Single Agent Chemotherapy as First Line Treatment for Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer With Eastern Cooperative Oncology Group (ECOG) Performance Status of 2
NCT04297605
Living Donor Liver Transplant for Unresectable Colorectal Liver Metastases
NCT05248581
A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell Lymphoma
NCT03758989
Skin Microbial Ecology in Atopic Dermatitis
NCT04170244
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
NCT03739502
Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer
NCT03706027
Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI
NCT03137095
Umbilical Cord Blood Transplantation From Unrelated Donors
NCT03016806
Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome
NCT01311258
Clinical and Neuropsychological Investigations in Batten Disease
NCT01873924
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry
NCT00082108
Advancing Cervical Cancer Screening Through the Emergency Department - IIS
NCT06796738
Health Protection and Promotion of Sign Language Interpreters Through Implementation of Total Worker Health®
NCT06058949
Safety, Feasibility, and Tolerability of Sulforaphane in Children with Chronic Kidney Disease
NCT05653492
Safety, Feasibility and Efficacy of Sulforaphane (Avmacol Extra Strength) in Chronic Kidney Disease
NCT05797506
Insertable Cardiac Monitor for Primary Atrial Fibrillation Detection in High-Risk Heart Failure Patients
NCT04818645
Team-Based Home Blood Pressure Monitoring
NCT05488795
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 66 |
| Phase 2 | 81 |
| Phase 3 | 20 |
| Phase 4 | 34 |
Therapeutic Areas
What is open in the University of Rochester pipeline
94 recruiting of 636 indexed (15% open); 448 completed (70%).
Phase mix: 54 late (III/IV) vs 147 early (I/II) (early-phase heavy).
Top condition: Cancer (7 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Rochester: open-pipeline peers nationwide
Peers matched on 636 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Rochester sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 636 trials (± recruiting share)
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Southern California · 617 trials · 16% recruiting
- Baylor College of Medicine · 616 trials · 15% recruiting
- University of California, Davis · 657 trials · 19% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Loma Linda University · 15% recruiting · 237 trials
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Brown University · 15% recruiting · 231 trials
Related
What to do with this University of Rochester page
636 registered trials is a research-attention snapshot, not an endorsement of University of Rochester or any single study.
- 94 of University of Rochester's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of Rochester studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Rochester pipeline card: 636 registered trials from official public datasets.Report a data error.